Seegene Inc (096530) - Total Liabilities

Latest as of September 2025: ₩214.46 Billion KRW ≈ $145.34 Million USD

Based on the latest financial reports, Seegene Inc (096530) has total liabilities worth ₩214.46 Billion KRW (≈ $145.34 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 096530 shareholders equity momentum to track the company's year-over-year net asset growth rate.

Seegene Inc - Total Liabilities Trend (2012–2024)

This chart illustrates how Seegene Inc's total liabilities have evolved over time, based on quarterly financial data. See Seegene Inc (096530) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Seegene Inc Competitors by Total Liabilities

The table below lists competitors of Seegene Inc ranked by their total liabilities.

Company	Country	Total Liabilities
ENEFIT GREEN AS F:I6B	Germany	€345.77 Million
Guangzhou Automobile Group Co. Ltd F:02G	Germany	€115.67 Billion
PT Arkora Hydro Tbk JK:ARKO	Indonesia	Rp1.09 Trillion
HMC Capital Ltd AU:HMC	Australia	AU$299.20 Million
Kodiak AI, Inc. Common Stock NASDAQ:KDK	USA	$153.55 Million
Cansino Biologics Inc SHG:688185	China	CN¥-4.93 Billion
PMB Technology Bhd KLSE:7172	Malaysia	RM1.16 Billion
Multi Bintang Indonesia Tbk JK:MLBI	Indonesia	Rp2.01 Trillion

Liability Composition Analysis (2012–2024)

This chart breaks down Seegene Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Seegene Inc stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.83	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.21	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.18	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Seegene Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Seegene Inc (2012–2024)

The table below shows the annual total liabilities of Seegene Inc from 2012 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩223.80 Billion ≈ $151.67 Million	+1.24%
2023-12-31	₩221.05 Billion ≈ $149.80 Million	-9.03%
2022-12-31	₩243.01 Billion ≈ $164.68 Million	-40.49%
2021-12-31	₩408.31 Billion ≈ $276.71 Million	-9.11%
2020-12-31	₩449.26 Billion ≈ $304.46 Million	+940.74%
2019-12-31	₩43.17 Billion ≈ $29.25 Million	+20.65%
2018-12-31	₩35.78 Billion ≈ $24.25 Million	-10.10%
2017-12-31	₩39.80 Billion ≈ $26.97 Million	-39.37%
2016-12-31	₩65.65 Billion ≈ $44.49 Million	+11.35%
2015-12-31	₩58.96 Billion ≈ $39.95 Million	+35.17%
2014-12-31	₩43.62 Billion ≈ $29.56 Million	-2.19%
2013-12-31	₩44.59 Billion ≈ $30.22 Million	+7.00%
2012-12-31	₩41.68 Billion ≈ $28.24 Million	--

About Seegene Inc

KQ:096530 Korea Biotechnology

Market Cap

$840.63 Million

₩1.24 Trillion KRW

Market Cap Rank

#9507 Global

#238 in Korea

Share Price

₩26900.00

Change (1 day)

+6.96%

52-Week Range

₩21850.00 - ₩32000.00

All Time High

₩140042.88